文献速递生殖医学

阿那曲唑在少精子症合并低雄激素的生育力低下男性中的结局

Outcomes of anastrozole in oligozoospermic hypoandrogenic subfertile men.
PubMed 文献 · Fertil Steril · 2017-01-06

回顾性研究纳入86例低雄激素的生育力低下男性,口服阿那曲唑1 mg/日。95.3%患者血清睾酮升高、雌二醇下降;21例少精子症中18例精液参数改善,且总活动精子数增加幅度与睾酮/雌二醇比值变化显著相关。

要点

  • 阿那曲唑1 mg/日使95.3%低雄激素男性血清睾酮升高、雌二醇下降。
  • 少精子症患者中18/21例精子浓度和总活动精子数改善。
  • 总活动精子数增加与睾酮/雌二醇比值变化显著相关。

核心结论

  • 约95%低雄激素男性内分泌参数改善,约25%的少精子症患者精子参数显著改善,且与睾酮/雌二醇比值变化相关,支持治疗的生理效应。

研究设计与样本

  • 回顾性研究,纳入86例低雄激素的生育力低下男性,其中低睾酮/雌二醇比值78例,既往对枸橼酸氯米芬有不良反应8例。

主要发现

  • 95.3%患者治疗后血清睾酮升高、雌二醇下降。
  • 21例少精子症患者中18例精子浓度和总活动精子数改善,且总活动精子数增加幅度与睾酮/雌二醇比值变化显著相关。
  • 无精子症、隐匿精子症或精液正常者精液参数未见改善。

关键数值与推荐

  • 所有患者口服阿那曲唑1 mg/日。
  • 治疗前后进行激素分析(总睾酮、雌二醇、性激素结合球蛋白、白蛋白、FSH、LH,并计算生物可利用睾酮)和精液分析(计算总活动精子数)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether the change in sperm parameters in subfertile hypoandrogenic men treated with anastrozole is correlated to the magnitude of increase in testosterone (T) to estrogen ratio in men responding to treatment. DESIGN: Retrospective study. SETTING: Male fertility clinic. PATIENT(S): The study group consisted of 86 subfertile hypoandrogenic men with low T/estradiol (E2) ratio (n = 78) or a prior aversive reaction to clomiphene citrate (n = 8). INTERVENTION(S): All patients were treated with 1 mg anastrozole daily, administered orally. MAIN OUTCOME MEASURE(S): Hormone analysis and semen analysis before and after treatment were performed. Hormone analysis included measurements of total T, E2, sex-hormone binding globulin, albumin, FSH, and LH, and bioavailable T was calculated. Total motile sperm count was calculated from the semen analysis. RESULT(S): In all, 95.3% of patients had an increased serum T and decreased serum E2 after treatment with anastrozole. Sperm concentration and total motile counts improved in 18 of 21 subfertile hypoandrogenic oligozoospermic men treated with anastrozole. In these men the magnitude of total motile count increase was significantly correlated with the change in the T/E2 ratio. No improvement was seen in semen parameters of men with azoospermia, cryptozoospermia, or normozoospermia at presentation. CONCLUSION(S): Approximately 95% of men with hypoandrogenism responded with improved endocrine parameters, and a subset of oligozoospermic men (approximately 25% of all patients) displayed significantly improved sperm parameters. In that subset, increase in sperm parameters was correlated with the change in the T/E2 ratio, which argues for a physiologic effect of treatment.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Shoshany O, Abhyankar N, Mufarreh N, et al. Outcomes of anastrozole in oligozoospermic hypoandrogenic subfertile men. Fertil Steril. 2017. PMID: 28069178. doi:10.1016/j.fertnstert.2016.11.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。